Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial... More drugs in developmentDrug Information A to Z Drug List Treatment Options Drugs by Class Dosage Side Effects Medical Q & A Generic Drugs Harvard...
The ClinCalc DrugStats Database: analyzing prescription drug utilization data estimates for patients in the United States.
A comprehensive list of the US FDA’s Center for Drug Evaluation & Research (CDER)'s new drug therapy approvals for 2022. CDER approved 37 new drugs in 2022, down from50 in 2021, either as new molecular entities (NMEs) under New Drug Applications (NDAs), or as new therapeutic biologics...
Ameile for the first-line treatment of adult patients with locally advanced or metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 (L858R) substitution mutation-positive (new indication approved in 2021) has been included in the 2022 Drug List for the first time; XINYUE for ...
(c) Similar drugs: The list of FDA-approved drugs for treating colorectal cancer was extracted from the National Cancer Institute (NCI) website (https://www.cancer.gov/), and the drugs that had gene signatures for large intestine tissue or colorectal cancer cell lines in the iLINCS data...
On June 29, China NHSA issued the Work Plan for Adjusting the 2022 National Reimbursement Drug List, which lists drugs covered by basic national insurance.
A reference drug list named the Drug-Induced QT Prolongation Atlas (DIQTA) was introduced in 2022, focusing on the classification of 528 drugs for QT prolongation risk, a major DICT mechanism.14 CredibleMeds (https://crediblemeds.org/) provides a drug list that categorizes a total of 246 dru...
List of darknet markets for investigators .Ali Marketplace. .Apollon Market. .Asap. Tor market darknet Tor darknet markets Tor darknet market Top darknet markets Top darknet markets… Darknet market list aofforum-Apr 04, 2022 Darknetlive Darknet Market List White House Market Monopoly Market...
Pimitespib, licensed in Japan, is the first specific heat shock protein 90 (HSP90) inhibitor. Len-acapavir, the sole drug on the list targeting a non-human protein, inhibits the HIV-1 viral capsid.doi:10.1038/d41573-023-00068-ySorin Avram...
To date, the US Depo-Provera drug label does not mention the increased risk to patients of developing intracranial meningiomas, even though the European Union (EU) and the United Kingdom (UK) drug labels list meningioma under the “special warnings and precautions for use” section and advise ...